Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

RARE PHOTOS: 18 | Rare Historical Photos

A Chulalongkorn University virologist has warned about a potential surge in Covid-19 cases during the cold season that will likely peak in January.

Bangkok Post

AstraZeneca looks fighting fit despite the ills of the UK science sector

Brexit fallout plus funding fears mean an uncertain prognosis, but the firm will report good news this week

The Guardian - UK

Tesla Shifts China Factory Workers To US Plant, Complete European Approval For AstraZeneca's COVID-19 Shot, Tesla Eyes Cybertruck Commercialization Next Year: Top Stories Tuesday, Nov. 1

Bloomberg Tesla Migrates Shanghai Factory Workers To Boost US Plant Production

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Intel's Self-Driving Tech Firm Raises Over $800M In IPO, Alphabet Misses Q3 Earnings Expectations, Lyft Cuts Price For Monthly Subscription Plan: Top Stories Wednesday, Oct. 26

Benzinga

High Hopes for Nasal Covid Vaccines despite 'Disappointing' Trial

Nasal vaccines could still be a powerful future weapon in the fight against Covid-19 despite "disappointing" recent trial results for an AstraZeneca spray, experts say. By entering the body the same way as the virus, nasal vaccines aim to build immunity in the mucous membrane that lines the nose and…

Asharq Al-Awsat

What vaccine can you get, based on your age? These are the recommended COVID-19 vaccines for each age group

More than 14.2 million Australians over the age of 16 have now received three or more doses. So which are the best vaccines for each age group?

ABC News

Super-gene that generates higher antibodies against Covid discovered

People carrying the super-gene recorded higher antibody responses against the Covid-19 vaccines 28 days following the first dose

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

Japan reopening: What are the current travel rules and do I need a Covid test?

The country reopened to individual tourists on 11 October

The Independent UK

Hillary Clinton giving girls Instagram access to ‘stand up for gender equality’

The former US presidential hopeful was supporting the United Nations’ International Day Of The Girl.

The Independent UK

Covid: hopes for Oxford nasal vaccine dealt blow after poor trial results

Scientists ditch plans to develop nasal spray version of Oxford/AstraZeneca vaccine in its current form

The Guardian - UK

Ex-vaccine head accuses Hancock of ‘Jekyll and Hyde’ behaviour in meeting

Dame Kate Bingham says former health secretary aggressively questioned her competence in front of cabinet

The Guardian - UK

Trainee solicitor died from ‘rare complication’ of AstraZeneca Covid-19 jab

Oli Akram Hoque, 26, developed a “vaccine induced” cerebral venous sinuous thrombosis after his first dose of AstraZeneca’s Covid-19 vaccine.

The Independent UK

Pollen does more than make you sneeze. It can cause thunderstorm asthma, even if you're not asthmatic

Climate change has caused melting icebergs, flooding, and landslides. It can also bring about an increase in pollen levels, prolong the duration of pollen season, and cause more pollen-related health problems.

The Conversation

Why Oil-Related Stocks Traded Higher; Here Are 74 Biggest Movers From Yesterday

Gainers LogicBio Therapeutics, Inc. (NASDAQ: LOGC) shares surged 637.6% to close at $2.01 on Monday after the company announced it will be acquired by AstraZeneca's subsidiary, Alexion, for $2.07 per share.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Why Tesla Shares Are Trading Lower By Over 7%, Here Are 52 Stocks Moving In Monday's Mid-Day Session

Gainers LogicBio Therapeutics, Inc. (NASDAQ: LOGC) gained 641% to $2.0207 after the company announced it will be acquired by AstraZeneca's subsidiary, Alexion, for $2.07 per share.

The Guardian - UK

Revealed: the budget bonanza for UK’s best-paid bosses from Tory tax cut

Scrapping top rate of tax could save hundreds of thousands for some of the highest earners, analysis reveals

Daily Record

Hamilton Accies Community Trust in cash boost from global pharmaceutical firm

AstraZeneca is supporting the work the Trust does across the Lanarkshire community.

Benzinga

Top Financial Stories Tuesday, September 13: Elon Musk's Takeover Set To Get Twitter Shareholder Approval, Intel Slashes Mobileye IPO Valuation, Goldman Sachs To Layoff About 500 Jobs And More…

Wall Street Journal

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Important Biotech Catalysts For September 9, 2022 - End Of The Day Summary

The U.S. Food and Drug Administration (FDA) has approved Spectrum Pharmaceuticals’ (NASDAQ:SPPI) lead asset ROLVEDON (eflapegrastim-xnst) injection to decrease the incidence of infection, as manifested by febrile neutropenia. Spectrum Pharmaceuticals shares traded as high as 3.17 percent, in a range of $1.21 to $1.30 on day volume of 6.8 million…

Benzinga

Important Biotech Catalysts For September 7, 2022 - End Of The Day Summary

The U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to Pfizer’s (NYSE:PFE) lead drug GBS6 or PF-06760805 for the prevention of invasive GBS disease due to the vaccine serotypes in newborns and young infants by active immunization of their mothers during pregnancy. Pfizer shares traded in a…

Evening Standard

AstraZeneca clears US regulatory hurdle for new cancer drug Imfinzi

The drug reduces the risk of death by 20% compared with chemotherapy alone

The Conversation

Better COVID vaccines are on the way. What do they do? And what technology might we see in future?

Regulators in Australia and the United States last week approved Omicron-specific boosters, following approval in the United Kingdom in mid-August.

ABC News

Viral claims are blaming a surge in excess deaths in Europe on vaccines. But experts say that's not the case

A jump in the number of deaths among children in Europe could be caused by numerous factors, experts said, but vaccines are not to blame.

Evening Standard

AstraZeneca hails heart disease breakthrough after patient trials

The company first developed the drug as a treatment for type-2 diabetes

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 29, 2022

Upgrades

1 … 17 18 19 20

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.